Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

JOHNSON & JOHNSON (JNJ) Stock Price Prediction and News Highlight
Mon. Nov 17, 2025

Johnson & Johnson's commitment to innovation is evidenced by its participation in healthcare conferences and strategic growth initiatives aimed at expanding its product portfolio, particularly in high-growth markets like cancer treatment. The company is also making notable advancements in surgical robotics and psoriatic arthritis treatment, showcasing its focus on modern medical technologies and effective therapies. However, challenges in clinical trials and drug development, such as the halt of a significant heart drug trial, pose risks to their product/service development efforts.

The price action of JOHNSON & JOHNSON (JNJ) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.7 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for JNJ since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.7, and the negative at 0 on 2025-11-17. The forces of and () will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), Valuation Sentiment (1.7), and Sentiment towards Fundamentals (2.6) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2026-01-21 06:30, EPS: $10.35, P/E: 19.28

JNJ
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2025-11-170%(0%)    0    0%    0.7          2.6    4   
2025-11-160%(0%)    0    0%    0.8          2.6    -1   
2025-11-150%(0%)    0    0%    0.9          2.5    -1   
2025-11-140%(0%)    0    0%    0.9          2.5    -1   
2025-11-130%(0%)    0    0%    0.9          3.1    -1   
2025-11-120%(0%)    0    0%    1          3.4    -1   
2025-11-110%(0%)    0    0%    0.9          2.9    -1   
2025-11-100%(0%)    0    0%    0.3          2.6    -1   
2025-11-090%(0%)    0    0%    -0.1          0.2    -1   
2025-11-080%(0%)    0    0%    -0.1          0.2    -1   
 
Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.
Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2025-11-17 17:03:23 Changes in leadership and strategic direction at Johnson & Johnson are influencing the company's future growth potential and operational focus.
2025-11-17 17:03:23 Recent stock activity and investment decisions related to Johnson & Johnson reflect the market's response to the company's strategic moves and overall health.
2025-11-17 17:03:23 New data supporting the efficacy of TREMFYA in treating active psoriatic arthritis showcases significant advancements in the company's product offerings.
2025-11-17 17:03:23 The discussion surrounding the investment potential in Johnson & Johnson versus competitors emphasizes the company's diversified strengths.
2025-11-17 17:03:23 Johnson & Johnson's acquisition of Halda Therapeutics highlights their commitment to expanding their oncology portfolio and enhancing treatment options for solid tumors.
2025-11-17 09:36:36 The acquisition represents a strategic initiative by Johnson & Johnson to diversify and expand its product offerings in the cancer treatment market.
2025-11-17 09:36:36 The need for Johnson & Johnson to acquire Halda Therapeutics indicates challenges with decreasing sales from its major psoriasis drug.
2025-11-17 09:36:36 Johnson & Johnson's acquisition of Halda Therapeutics highlights a proactive investment strategy in the biotechnology sector, particularly in cancer treatments.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA